Overweight: Clinical Trials

34 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

34 unknown. 34 Phase 1, 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 134Unknown 34
Phase 210Unknown 10

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 34 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanisms of Semaglutide Therapy in Heart Failure Patients
Semaglutide - Heart Failure, Obesity
Phase 1 / Phase 2UnknownUniversity Medical Centre Ljubljana102024-07-102024-08-07
Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)
D piger, Placebo - Obesity, Metabolic Syndrome
Phase 1UnknownMax Nieuwdorp202024-05-012024-07-16
A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers
Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical® - Overweight or Obesity
Phase 1UnknownEmpros Pharma AB202023-09-222023-10-04
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
HFFS - Osteoarthritis, Knee, Obesity
Phase 1 / Phase 2UnknownUniversity of Southern Mississippi242023-07-012023-08-18
Evaluation of the Colonization Capacity of a Probiotic Bacterium.
Probiotic - Obese, Weight, Body
Phase 1UnknownValencian Innovation Agency152023-06-012023-05-26
Comparative Effects of Using Black Seed and Cumin Seed on BCP of Obese Grade I
Black Seed ( Nigella Sativa), Cumin Seed (Cuminum Cyminum) - Obese
Phase 1UnknownSehat Medical Complex552023-01-272023-03-15
Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients
Direct Peritoneal Resuscitation - End Stage Liver DIsease, Obesity
Phase 1UnknownUniversity of Colorado, Denver152022-02-012023-06-08
Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release
Quinine Hydrochloride, Placebo - Obesity
Phase 1UnknownUniversitaire Ziekenhuizen KU Leuven402020-10-292024-07-03
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
MET-3 - Obesity, Metabolically Benign
Phase 1UnknownNuBiyota202020-06-222020-08-11
Bariatric Embolization Trial for the Obese Nonsurgical
Left gastric artery embolization - Obesity, Weight Loss
Phase 1UnknownUniversity of Calgary52018-09-012018-07-26
Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems
Ursodeoxycholic acid, Metformin, Placebo - Overweight, Abnormal Liver Function Tests
Phase 1UnknownSeoul National University Hospital302016-08-012016-12-23
Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers
Obeticholic acid, Obeticholic acid placebo - Obesity
Phase 1UnknownSahlgrenska University Hospital402015-08-012020-08-25
To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects
KD101, placebo - Obesity
Phase 1UnknownKwang Dong Pharmaceutical co., ltd.382015-03-012015-06-03
Effect of Entacapone on Bodyweight Loss in Obese Population
Entacapone, Placebo - Obesity
Phase 1 / Phase 2UnknownKaichun Wu302015-01-012015-02-02
Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
Deep Brain Stimulation - Prader-Willi Syndrome
Phase 1UnknownUniversity of Sao Paulo General Hospital62014-10-012015-12-16
New Therapeutic Perspectives in Obesity
Phototherapy - Obesity;
Phase 1UnknownUniversidade Federal de Sao Carlos642014-09-012014-06-02
Effects of Intake of a Polysaccharides Mix on Metabolism, Hormones and Satiety in Obese Children.
Placebo, Libramed - Obesity
Phase 1 / Phase 2UnknownAzienda Ospedaliera Universitaria Integrata Verona1202014-01-012021-01-13
Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study
Enoxaparin 40 mg 2 hours before arm, Enoxaparin 40 mg 12 hours before arm - Morbid Obesity, Pulmonary Embolism
Phase 1 / Phase 2UnknownMansoura University7002013-11-012015-04-08
Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study
Air filled balloon, Bioenteric BIB® balloon - Morbid Obesity, Weight Loss
Phase 1 / Phase 2UnknownMansoura University3002013-09-012015-04-08
Effect of Gastric Balloon in Morbid Obesity: Prospective Study
BMI more than 45 BMI, BMI less than 45 BMI - Morbid Obesity
Phase 1 / Phase 2UnknownMansoura University3002013-08-012015-04-08

Showing 20 of 34. Sign in to see all of them.

Narrower conditions

Obesity (25)  ·  Obesity, Morbid (5)  ·  Insulin Resistance (4)  ·  Weight Loss (4)  ·  Metabolic Syndrome (3)  ·  Body Weight (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Heart Failure (2)  ·  Acute Kidney Injury (1)  ·  Atherosclerosis (1)  ·  Bone Resorption (1)  ·  Diabetes, Gestational (1)  ·  End Stage Liver Disease (1)  ·  Fatty Liver (1)

Broader conditions

Nutrition Disorders (34)  ·  Nutritional and Metabolic Diseases (34)  ·  Overnutrition (34)  ·  Pathological Conditions, Signs and Symptoms (34)  ·  Signs and Symptoms (33)  ·  Body Weight (31)  ·  Glucose Metabolism Disorders (6)  ·  Hyperinsulinism (6)  ·  Metabolic Diseases (6)  ·  Cardiovascular Diseases (5)  ·  Obesity (5)  ·  Body Weight Changes (4)  ·  Diabetes Mellitus (3)  ·  Endocrine System Diseases (3)

Interventions

(1-6)-alpha-glucomannan (1)  ·  Adiposity (1)  ·  Cognitive Behavioral Therapy (1)  ·  Deep Brain Stimulation (1)  ·  Diet (1)  ·  Diet, Reducing (1)  ·  Enoxaparin (1)  ·  Exercise (1)  ·  Lasers (1)  ·  Low-Level Light Therapy (1)  ·  Metformin (1)  ·  Nigella sativa oil (1)  ·  Phototherapy (1)  ·  Probiotics (1)  ·  Quinine (1)

Sponsors

Mansoura University (3)  ·  Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  Bayside Health (1)  ·  Central FITT, Inc (1)  ·  Empros Pharma AB (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Federal University of São Paulo (1)  ·  German Diabetes Center (1)  ·  Hospital Sao Joao (1)  ·  Kaichun Wu (1)  ·  Kwang Dong Pharmaceutical co., ltd. (1)  ·  Landspitali University Hospital (1)  ·  Max Nieuwdorp (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  NuBiyota (1)

Countries

United States (7)  ·  Belgium (3)  ·  Brazil (3)  ·  Canada (3)  ·  Egypt (3)  ·  Italy (2)  ·  South Korea (2)  ·  Sweden (2)  ·  Australia (1)  ·  China (1)  ·  Germany (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  Portugal (1)

Top investigators

Anahita Mistry, PhD (1)  ·  Andrea Gaggioli, PhD (1)  ·  Claudio Maffeis, MD (1)  ·  Darshan Bakshi, MD (1)  ·  Debra A. Krummel, PhD, RD (1)  ·  Dirk Vissers (1)  ·  Durval Damiani (1)  ·  Emeka Nzekwu, MD (1)  ·  Fiona J Adams, BSc. Grad Dip Diet (1)  ·  Giuseppe Riva, PhD (1)  ·  Gonzalo Torres-Villalobos, MD (1)  ·  Hanns-Ulrich Marschall (1)  ·  Howard Lee, Professor (1)  ·  Hunter B Moore, M.D., P.hD. (1)

Results publications

PMID 18400730, PMID 18491071, PMID 19142567, PMID 19487105, PMID 20551965, PMID 20847735, PMID 21464376, PMID 21997144, PMID 22136774, PMID 23361157, PMID 24472122, PMID 26084343, PMID 29053802, PMID 36413425, PMID 42028108

NIH funding

2023 (1)